WVE

Wave Life Sciences Ltd.

5.50 USD

Last updated Dec 3, 04:31 UTC

Yesterday HIGH

$5.69

Yesterday LOW

$5.27

52w HIGH

$7.12

52w LOW

$3.15

EPS

0.07

PE

78.57

Next Earnings

Mar 20, 2024

Overview News Government Trades

Wave Life Sciences Ltd. stock is down -2.48% since 30 days ago. The next earnings date is Mar 20, 2024. The company has had above-average volume in the last 30 days. Its seasonality going into this month shows a chance of a red month, as 22.22% of the previous 8 December’s closed higher than November.

Wave Life Sciences Ltd., a clinical stage genetic medicine company, designs, optimizes, and produces novel stereopure oligonucleotides. The company also develops WVE-004, a C9orf72 molecule for the treatment of amyotrophic lateral sclerosis and frontotemporal dementia. It focuses on developing GalNAc-conjugated AIMers to treat hepatic indications.

Stock Exchange

NASDAQ

Sector

Manufacturing

Industry

Pharmaceutical Products

Headquarters

Singapore, Singapore

Website

wavelifesciences.com

Benzinga Newsdesk

Tue May 23, 2023

Wave Life Sciences shares are trading lower after the company announced WVE-004 did not show clinical benefit compared with the placebo.
Benzinga Newsdesk

Tue May 23, 2023

Wave Life Sciences Shares Resume Trading, Move Lower
Benzinga Newsdesk

Tue May 23, 2023

Wave Life Sciences Says WVE-004 Did Not Show Clinical Benefit Compared With Placebo

Wave remains on track to share data from its Phase 1b/2a SELECT-HD study in Huntington's disease investigating WVE-003 in the second half of 2023. The company is also rapidly advancing WVE-N531 for Duchenne muscular
Benzinga Newsdesk

Tue May 23, 2023

Wave Life Sciences Shares Halted, News Pending
Benzinga Insights

Wed May 10, 2023

WAVE Life Sciences's Return On Capital Employed Overview
richadhand@benzinga.com

Thu May 4, 2023

RBC Capital Reiterates Sector Perform on WAVE Life Sciences, Maintains $5 Price Target

RBC Capital analyst Luca Issi reiterates WAVE Life Sciences (NASDAQ:WVE) with a Sector Perform and maintains $5 price target.
Lisa Levin

Wed May 3, 2023

Estee Lauder, NerdWallet, Sprout Social And Other Big Stocks Moving Lower On Wednesday

U.S. stocks mostly traded higher, but the Dow Jones lost around 19 points on Wednesday. Here are some big stocks recording losses in today’s session.
Benzinga Insights

Wed May 3, 2023

Recap: WAVE Life Sciences Q1 Earnings
Benzinga Newsdesk

Wed May 3, 2023

WAVE Life Sciences Q1 EPS $(0.27) Misses $(0.04) Estimate, Sales $12.93M Miss $32.33M Estimate

WAVE Life Sciences (NASDAQ:WVE) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.04) by 575 percent. This is a 56.45 percent increase over losses of $(0.62) per share from
Benzinga Newsdesk

Thu Apr 20, 2023

Wave Life Sciences Announces Nucleic Acids Research Publication Highlighting Potential Best-In-Class siRNAs Designed With Wave Platform Chemistry

Published preclinical data demonstrate unprecedented Ago2 loading following administration of single subcutaneous siRNA dose, leading to improved potency and durability in vivo versus comparator siRNA formats RNAi